For the quarter ending 2026-03-31, CODX has $21,499,726 in assets. $5,457,316 in debts. $8,230,984 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 8,230,984 | 11,884,607 | 11,443,943 | 11,115,181 |
| Marketable investment securities | - | - | - | 2,247,638 |
| Accounts receivable, net | 82,339 | 190,375 | 55,905 | 210,968 |
| Inventory, net | 846,119 | 992,397 | 1,089,956 | 1,084,627 |
| Income taxes receivable | 49 | 44,559 | 923,217 | - |
| Prepaid expenses and other current assets | 622,760 | 581,527 | 541,946 | 648,752 |
| Total current assets | 9,782,251 | 13,693,465 | 14,054,967 | 15,307,166 |
| Property and equipment, net | 2,158,670 | 2,272,098 | 2,485,112 | 2,673,390 |
| Operating lease right-of-use asset | 2,002,597 | 1,207,453 | 1,439,779 | 1,668,416 |
| Intangible assets, net | 7,219,000 | 7,219,000 | 26,101,000 | 26,101,000 |
| Investment in joint ventures | 337,208 | 350,569 | 659,903 | 715,861 |
| Total assets | 21,499,726 | 24,742,585 | 44,740,761 | 46,465,833 |
| Accounts payable | 2,017,852 | 1,878,225 | 1,458,397 | 1,635,196 |
| Accrued expenses | 1,364,754 | 865,301 | 1,204,660 | 1,008,127 |
| Operating lease liability, current | 857,638 | 662,258 | 744,156 | 824,458 |
| Contingent consideration liabilities, current | 43,756 | 119,036 | 239,955 | 197,610 |
| Deferred revenue | 600 | 14,800 | 45,557 | 45,857 |
| Contingent consideration liabilities | - | - | - | 0 |
| Total current liabilities | 4,284,600 | 3,539,620 | 3,692,725 | 3,711,248 |
| Income taxes payable | - | - | 491,848 | 736,933 |
| Operating lease liability | 1,172,716 | 574,301 | 727,943 | 879,258 |
| Total long-term liabilities | 1,172,716 | 574,301 | 1,219,791 | 1,616,191 |
| Total liabilities | 5,457,316 | 4,113,921 | 4,912,516 | 5,327,439 |
| Common stock, 0.001 par value 100,000,000 shares authorized 3,764,088 shares issued and 3,602,465 shares outstanding as of march 31, 2026 and 2,256,654 shares issued and 2,095,031 shares outstanding as of december 31, 2025 | 69,207 | 67,700 | 52,991 | 41,031 |
| Treasury stock, at cost 161,623 shares held as of march 31, 2026 and december 31, 2025, respectively | 15,575,795 | 15,575,795 | 15,575,795 | 15,575,795 |
| Additional paid-in capital | 121,062,575 | 116,510,298 | 109,447,214 | 104,843,320 |
| Accumulated other comprehensive income | - | - | 94,888 | 134,068 |
| Accumulated deficit | -89,513,577 | -80,373,539 | -54,191,053 | -48,304,230 |
| Total stockholders equity | 16,042,410 | 20,628,664 | 39,828,245 | 41,138,394 |
| Total liabilities and stockholders equity | 21,499,726 | 24,742,585 | 44,740,761 | 46,465,833 |
Co-Diagnostics, Inc. (CODX)
Co-Diagnostics, Inc. (CODX)